- Help prepare the next GSK brief with Michael Alexander’s WikiBriefs.
Intellectual Ventures plans to spend $2 billion over the next several years on patent rights. The ‘non-producing entity’ has been largely shut-out from top US university technology transfer deals because many universities and is now refocusing on doing deals with non-US universities and researchers. US universities are not interested in selling because they want their licensees to develop the technologies. IntVen CEO Nathan Myhrvold told the WSJ that his company has not yet sued anyone for patent infringement. (See WSJ Blog). - PatentDocs blog is one year old. Congratulations on a great start! [Link] (The senior patent doc – Dr. Kevin Noonan – is pictured at right).
- Patent Troll Tracker also provides a milestone — his 100th post. In that post, PTT calls for patent reform. He’s upset by “the numerous multi-defendant patent litigation cases being brought by non-practicing entities and patent trolls in the Eastern District of Texas.” [Link]
- David Donoghue posts his “Blawg Review.”
Intellectual Ventures plans to spend $2 billion over the next several years on patent rights. The ‘non-producing entity’ has been largely shut-out from top US university technology transfer deals because many universities and is now refocusing on doing deals with non-US universities and researchers. US universities are not interested in selling because they want their licensees to develop the technologies. Recent Jobs:
-
Interested in switching to academia? UConn Law School wants to hire a patent attorney to serve as a Clinical Professor: Assistant/Associate Clinical Professor of Law.